Prescribing guidelines
-
CVS: Choice of DOAC for prevention of stroke and systemic embolism in AF-Apixaban
Cardiovascular and Lipids -
CVS: Chronic Coronary Syndrome - Stable Angina (APC Approved)
Cardiovascular and Lipids -
CVS: Furosemide (frusemide)- Guidance for prescribing Subcutaneous Furosemide
Cardiovascular and LipidsGuidance for the assessment and treatment of end stage heart failure by subcutaneous furosemide for the treatment of symptomatic fluid overload
-
CVS: Hypertension - antihypertensive medication (APC approved)
Cardiovascular and Lipids Endocrine and Diabetes -
CVS: NOAC- management of bleeding
Cardiovascular and Lipids Laboratory investigations and Infections -
CVS: NOACS - newer oral anticoagulants
Cardiovascular and Lipids Laboratory investigations and Infections -
CVS: Spironolactone - Position Statement on MHRA Drug Safety Update
Cardiovascular and Lipids -
CVS: Switching Between Oral Anticoagulants
Cardiovascular and Lipids
Did you find this page helpful?